Safety and Efficacy of the CELT ACD Femoral Arteriotomy Closure Device in the Office-based Laboratory

Abstract

Manual compression remains the gold standard for achieving hemostasis for percutaneous common femoral artery access. However, it requires prolonged bed rest and 20-30 minutes or more of compression for hemostasis. Current arterial closure devices have emerged in recent years, but they are still associated with significant access device complications, including hematoma, retroperitoneal bleeding, transfusion requirement, pseudoaneurysm, arteriovenous fistula, and arterial thrombosis. A novel femoral access closure device, the CELT ACD (Vasorum Ltd), has been previously shown to reduce these complication rates and allow rapid hemostasis and time to ambulation and discharge.